Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8247256 | 0.83 | MAPT (0.54) | ALDH1A1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL12622681 | 0.83 | LMNA (0.53) | ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL10931456 | 0.83 | MAPK1 (0.59) | ALDH1A1SMN1; SMN2AR | |
| SCHEMBL507298 | 0.82 | AR (0.45) | ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL8624905 | 0.81 | PTGS2 (0.51) | ALDH1A1MEN1KMT2AKDM4ESMN1; SMN2 | |
| SCHEMBL12622683 | 0.81 | SMN1; SMN2 (0.71) | ALDH1A1MEN1KMT2ASMN1; SMN2POLB | |
| SCHEMBL11169076 | 0.81 | MAPT (0.49) | ALDH1A1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL421801 | 0.81 | ALOX15 (0.61) | ALDH1A1MEN1KMT2ASMN1; SMN2MAPT | |
| SCHEMBL7708595 | 0.80 | SMN1; SMN2 (0.46) | ALDH1A1SMN1; SMN2MAPTAR | |
| SCHEMBL7702919 | 0.80 | SMN1; SMN2 (0.46) | ALDH1A1SMN1; SMN2MAPTAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321732-B2 | Phenyl(oxy/thio)alkanol derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-04-26 | — | — | US | disclosed |
| US-9051277-B2 | Phenyl(oxy/thio)alkanol derivatives | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-06-09 | — | — | US | disclosed |
| US-20140357649-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2014-12-04 | — | — | US | disclosed |
| EP-2451784-A1 | PHENYL(OXY/THIO)ALKANOL DERIVATIVES | Bayer CropScience AG (DE) | 2012-05-16 | — | — | EP | disclosed |
| US-20110039865-A1 | Phenyl(oxy/thio)alkanol Derivatives | BAYER CROPSCIENCE AG (DE) | 2011-02-17 | — | — | US | disclosed |
| WO-2011003527-A1 | PHENYL(OXY/THIO)ALKANOL DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2011-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140357649-A1 | Phenyl(oxy/thio)alkanol Derivatives | MYB, ALKBH3, OSBP | ALDH1A1 1776/4885MEN1 4876/4885KMT2A 2176/4885 |
| US-20110039865-A1 | Phenyl(oxy/thio)alkanol Derivatives | MYB, ALKBH3, OSBP | ALDH1A1 1776/4885MEN1 4876/4885KMT2A 2176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.